510(k) K872175
K872175 is an FDA 510(k) premarket notification submitted by Abbott Laboratories for the device "TDXR FLECAINIDE". The FDA issued a decision of Substantially Equivalent on August 13, 1987. The device falls under product code LBZ (Enzyme Immunoassay, Quinidine), a Class II device regulated under 21 CFR 862.3320. Abbott Laboratories has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- August 13, 1987
- Date Received
- June 8, 1987
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Enzyme Immunoassay, Quinidine
- Device Class
- Class II
- Regulation Number
- 862.3320
- Review Panel
- TX
- Submission Type